Donor-Specific Antibodies (DSA) have been shown to play a role in both chronic and acute rejection of transplanted allografts. It provides superior solutions for DSA detection in transplant samples. DSA testing enables the screening of antibodies developed against the donor’s HLA antigens. It is ideal for pre- and post-transplant testing.